Anticancer Activity of Morphine and Its Synthetic Derivative, KT-90, Mediated through Apoptosis and Inhibition of NF-κB Activation
- 27 November 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 252 (3) , 566-570
- https://doi.org/10.1006/bbrc.1998.9695
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Morphine-6-glucuronide, a potent mu agonistPublished by Elsevier ,2002
- Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patientsPain, 1996
- Anti-cancer effects of morphine through inhibition of tumour necrosis factor-α release and mRNA expressionCarcinogenesis: Integrative Cancer Research, 1996
- Opioid and Opiate Immunoregulatory ProcessesCritical Reviews in Immunology, 1996
- Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective studyPain, 1995
- Design and synthesis of 10-oxo derivative of N-cyclopropylmethyl (−)-6β-acetylthiodihydro-normorphine, a potentially κ-selective opioid receptor ligandBioorganic & Medicinal Chemistry Letters, 1995
- Enhancement of experimental metastasis by tumor necrosis factor.The Journal of Experimental Medicine, 1993
- Oral morphine in cancer pain: influences on morphine and metabolite concentrationClinical Pharmacology & Therapeutics, 1990
- Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines.Proceedings of the National Academy of Sciences, 1990
- Identity of tumour necrosis factor and the macrophage-secreted factor cachectinNature, 1985